Facebook
Twitter
LinkedIn
ForwardImplementing Biosimilars: Lessons from the frontline
August 24, 2021
Biosimilars offer a tremendous opportunity to reduce the cost of care. However, unlike generic drugs, biosimilars present unique challenges in implementation and processes. To be successful, health systems must fully understand the barriers and opportunities available with biosimilar implementation. This webinar will discuss the results of a Vizient survey of biosimilar implementation and give examples of best practices, tips and tricks, and lessons learned from Vizient health systems that have successfully implemented biosimilars.
Target Audience
- Pharmacists
Learning Objectives
- Outline the barriers and opportunities present in implementing biosimilars within a health system
- Describe examples of successful implementation strategies to overcome the barriers and capitalize on the opportunities for implementing biosimilars in health systems
Additional Information
| Attachment | Size |
|---|---|
 Helpful Tips for Users - Vizient CE System.pdf | 134.66 KB |
 Information for CE Credit - Implementing Biosimilars_Lessons from the frontline.docx | 125.55 KB |
Live via webinar
United States
Relevant financial relationships: Scott Soefje received a speaker honorarium from Pfizer and has received consultant fees from Beigene.
Kasy Cross will discuss off-label use of drugs.
Planning committee members
Sybil Thomas, PharmD, MBA
Senior Director, Pharmacy
Vizient, Inc.
Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA
Director, Pharmacy Cancer Care
Mayo Clinic
Mary Golf, PharmD, BCOP
Pharmacy Manager, Hematology/Oncology
Northwestern Memorial Hospital
Kasy Cross, PharmD, BCOP
Supervising Pharmacist, Infusion Therapy
University of Alabama at Birmingham Health System
Suzanne Walton, PharmD, BCPS, BCOP
Clinical Pharmacist Specialist, Hematology/Oncology
Grady Health System
Hassaan Shaikh, PharmD
PGY2 Oncology Resident
University of Iowa Health
Melissa Rhoades, PharmD, BCOP
Clinical Oncology Pharmacist
Froedtert Hospital
Course reviewer
Sybil Thomas, PharmD, MBA
Senior Director, Pharmacy
Vizient, Inc.
Presenters
Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA
Director, Pharmacy Cancer Care
Mayo Clinic
Mary Golf, PharmD, BCOP
Pharmacy Manager, Hematology/Oncology
Northwestern Memorial Hospital
Kasy Cross, PharmD, BCOP
Supervising Pharmacist, Infusion Therapy
University of Alabama at Birmingham Health System
Suzanne Walton, PharmD, BCPS, BCOP
Clinical Pharmacist Specialist, Hematology/Oncology
Grady Health System
Joint Accreditation Statement:
In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Designation Statement:
PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-0000-21-173-L04-P
CEU
Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU).
Available Credit
- 1.00 ACPE Pharmacist